Last 12 months
Inside the activity.
0 purchase rows · 6 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 1 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 2 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 2 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 06, 2026 Filed Mar 10, 2026 20:06 UTC |
Phipps Chad FSee remarks below.
|
Exercise / conversionCommon Stock | 2,094 | $0.00 | $0.00 |
DisclosureSEC source: 0001346672-26-000008 · form4-03102026_080354.xml · nonDerivative · entry 3 Phipps Chad F · CIK 0001346672 · See remarks below. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 68,603 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 06, 2026 Filed Mar 10, 2026 20:06 UTC |
Phipps Chad FSee remarks below.
|
Tax withholdingCommon Stock | 1,889 | $92.54 | $174,808.06 |
DisclosureSEC source: 0001346672-26-000008 · form4-03102026_080354.xml · nonDerivative · entry 2 Phipps Chad F · CIK 0001346672 · See remarks below. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 66,509 F1 · shares: Represents shares withheld by Zimmer Biomet Holdings, Inc. (the "Company") to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs"). Read SEC document |
| March 06, 2026 Filed Mar 10, 2026 20:06 UTC |
Phipps Chad FSee remarks below.
|
Exercise / conversionCommon Stock | 4,692 | $0.00 | $0.00 |
DisclosureSEC source: 0001346672-26-000008 · form4-03102026_080354.xml · nonDerivative · entry 1 Phipps Chad F · CIK 0001346672 · See remarks below. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 68,398 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 25, 2026 Filed Feb 27, 2026 21:07 UTC |
VAN ZUILEN WILFREDGroup Pres, EMEA
|
Exercise / conversionRestricted Stock Units · Derivative | 3,182 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001864818-26-000006 · form4-02272026_090233.xml · derivative · entry 3 VAN ZUILEN WILFRED · CIK 0001864818 · Group Pres, EMEA 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,363 Underlying: Common Stock · 3,182 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: One-third of the RSUs vested on February 25, 2026. The remaining RSUs vest one-half on each of February 25, 2027 and February 25, 2028. F2 · derivative.expiration_date: One-third of the RSUs vested on February 25, 2026. The remaining RSUs vest one-half on each of February 25, 2027 and February 25, 2028. Read SEC document |
| February 25, 2026 Filed Feb 27, 2026 21:07 UTC |
VAN ZUILEN WILFREDGroup Pres, EMEA
|
Tax withholdingCommon Stock | 828 | $99.51 | $82,394.28 |
DisclosureSEC source: 0001864818-26-000006 · form4-02272026_090233.xml · nonDerivative · entry 2 VAN ZUILEN WILFRED · CIK 0001864818 · Group Pres, EMEA 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,809 F1 · shares: Represents shares withheld by Zimmer Biomet Holdings, Inc. (the "Company") to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs"). Read SEC document |
| February 25, 2026 Filed Feb 27, 2026 21:07 UTC |
VAN ZUILEN WILFREDGroup Pres, EMEA
|
Exercise / conversionCommon Stock | 3,182 | $0.00 | $0.00 |
DisclosureSEC source: 0001864818-26-000006 · form4-02272026_090233.xml · nonDerivative · entry 1 VAN ZUILEN WILFRED · CIK 0001864818 · Group Pres, EMEA 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,637 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 25, 2026 Filed Feb 27, 2026 21:06 UTC |
Phipps Chad FSee remarks below.
|
Exercise / conversionRestricted Stock Units · Derivative | 2,626 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001346672-26-000006 · form4-02272026_090238.xml · derivative · entry 3 Phipps Chad F · CIK 0001346672 · See remarks below. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,249 Underlying: Common Stock · 2,626 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: One-third of the RSUs vested on February 25, 2026. The remaining RSUs vest one-half on each of February 25, 2027 and February 25, 2028. F2 · derivative.expiration_date: One-third of the RSUs vested on February 25, 2026. The remaining RSUs vest one-half on each of February 25, 2027 and February 25, 2028. Read SEC document |
| February 25, 2026 Filed Feb 27, 2026 21:06 UTC |
Phipps Chad FSee remarks below.
|
Tax withholdingCommon Stock | 1,057 | $99.51 | $105,182.07 |
DisclosureSEC source: 0001346672-26-000006 · form4-02272026_090238.xml · nonDerivative · entry 2 Phipps Chad F · CIK 0001346672 · See remarks below. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 63,706 F1 · shares: Represents shares withheld by Zimmer Biomet Holdings, Inc. (the "Company") to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs"). Read SEC document |
| February 25, 2026 Filed Feb 27, 2026 21:06 UTC |
Phipps Chad FSee remarks below.
|
Exercise / conversionCommon Stock | 2,626 | $0.00 | $0.00 |
DisclosureSEC source: 0001346672-26-000006 · form4-02272026_090238.xml · nonDerivative · entry 1 Phipps Chad F · CIK 0001346672 · See remarks below. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 64,763 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 25, 2026 Filed Feb 27, 2026 21:05 UTC |
Yi SangGroup President, Asia Pacific
|
Exercise / conversionRestricted Stock Units · Derivative | 2,785 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001635943-26-000008 · form4-02272026_090254.xml · derivative · entry 2 Yi Sang · CIK 0001635943 · Group President, Asia Pacific 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,567 Underlying: Common Stock · 2,785 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: One-third of the RSUs vested on February 25, 2026. The remaining RSUs vest one-half on each of February 25, 2027 and February 25, 2028. F1 · derivative.expiration_date: One-third of the RSUs vested on February 25, 2026. The remaining RSUs vest one-half on each of February 25, 2027 and February 25, 2028. Read SEC document |
| February 25, 2026 Filed Feb 27, 2026 21:05 UTC |
Yi SangGroup President, Asia Pacific
|
Exercise / conversionCommon Stock | 2,785 | $0.00 | $0.00 |
DisclosureSEC source: 0001635943-26-000008 · form4-02272026_090254.xml · nonDerivative · entry 1 Yi Sang · CIK 0001635943 · Group President, Asia Pacific 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,837 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 25, 2026 Filed Feb 27, 2026 21:05 UTC |
Winkler LoriSVP and CHRO
|
Exercise / conversionRestricted Stock Units · Derivative | 2,347 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001852191-26-000006 · form4-02272026_090200.xml · derivative · entry 3 Winkler Lori · CIK 0001852191 · SVP and CHRO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,693 Underlying: Common Stock · 2,347 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: One-third of the RSUs vested on February 25, 2026. The remaining RSUs vest one-half on each of February 25, 2027 and February 25, 2028. F2 · derivative.expiration_date: One-third of the RSUs vested on February 25, 2026. The remaining RSUs vest one-half on each of February 25, 2027 and February 25, 2028. Read SEC document |
| February 25, 2026 Filed Feb 27, 2026 21:05 UTC |
Winkler LoriSVP and CHRO
|
Tax withholdingCommon Stock | 924 | $99.51 | $91,947.24 |
DisclosureSEC source: 0001852191-26-000006 · form4-02272026_090200.xml · nonDerivative · entry 2 Winkler Lori · CIK 0001852191 · SVP and CHRO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,418 F1 · shares: Represents shares withheld by Zimmer Biomet Holdings, Inc. (the "Company") to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs"). Read SEC document |
| February 25, 2026 Filed Feb 27, 2026 21:05 UTC |
Winkler LoriSVP and CHRO
|
Exercise / conversionCommon Stock | 2,347 | $0.00 | $0.00 |
DisclosureSEC source: 0001852191-26-000006 · form4-02272026_090200.xml · nonDerivative · entry 1 Winkler Lori · CIK 0001852191 · SVP and CHRO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,342 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 25, 2026 Filed Feb 27, 2026 21:04 UTC |
Upadhyay SuketuExec VP, CFO
|
Exercise / conversionRestricted Stock Units · Derivative | 6,364 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001533149-26-000007 · form4-02272026_090211.xml · derivative · entry 3 Upadhyay Suketu · CIK 0001533149 · Exec VP, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,726 Underlying: Common Stock · 6,364 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: One-third of the RSUs vested on February 25, 2026. The remaining RSUs vest one-half on each of February 25, 2027 and February 25, 2028. F2 · derivative.expiration_date: One-third of the RSUs vested on February 25, 2026. The remaining RSUs vest one-half on each of February 25, 2027 and February 25, 2028. Read SEC document |
| February 25, 2026 Filed Feb 27, 2026 21:04 UTC |
Upadhyay SuketuExec VP, CFO
|
Tax withholdingCommon Stock | 2,832 | $99.51 | $281,812.32 |
DisclosureSEC source: 0001533149-26-000007 · form4-02272026_090211.xml · nonDerivative · entry 2 Upadhyay Suketu · CIK 0001533149 · Exec VP, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 61,285 F1 · shares: Represents shares withheld by Zimmer Biomet Holdings, Inc. (the "Company") to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs"). Read SEC document |
| February 25, 2026 Filed Feb 27, 2026 21:04 UTC |
Upadhyay SuketuExec VP, CFO
|
Exercise / conversionCommon Stock | 6,364 | $0.00 | $0.00 |
DisclosureSEC source: 0001533149-26-000007 · form4-02272026_090211.xml · nonDerivative · entry 1 Upadhyay Suketu · CIK 0001533149 · Exec VP, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 64,117 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 25, 2026 Filed Feb 27, 2026 21:03 UTC |
Tornos IvanDirector · Chairman, President and CEO
|
Exercise / conversionRestricted Stock Units · Derivative | 19,090 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001757216-26-000006 · form4-02272026_090224.xml · derivative · entry 3 Tornos Ivan · CIK 0001757216 · Director · Chairman, President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,179 Underlying: Common Stock · 19,090 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: One-third of the RSUs vested on February 25, 2026. The remaining RSUs vest one-half on each of February 25, 2027 and February 25, 2028. F2 · derivative.expiration_date: One-third of the RSUs vested on February 25, 2026. The remaining RSUs vest one-half on each of February 25, 2027 and February 25, 2028. Read SEC document |
| February 25, 2026 Filed Feb 27, 2026 21:03 UTC |
Tornos IvanDirector · Chairman, President and CEO
|
Tax withholdingCommon Stock | 10,557 | $99.51 | $1,050,527.07 |
DisclosureSEC source: 0001757216-26-000006 · form4-02272026_090224.xml · nonDerivative · entry 2 Tornos Ivan · CIK 0001757216 · Director · Chairman, President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 67,682 F1 · shares: Represents shares withheld by Zimmer Biomet Holdings, Inc. (the "Company") to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs"). Read SEC document |
| February 25, 2026 Filed Feb 27, 2026 21:03 UTC |
Tornos IvanDirector · Chairman, President and CEO
|
Exercise / conversionCommon Stock | 19,090 | $0.00 | $0.00 |
DisclosureSEC source: 0001757216-26-000006 · form4-02272026_090224.xml · nonDerivative · entry 1 Tornos Ivan · CIK 0001757216 · Director · Chairman, President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 78,239 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 25, 2026 Filed Feb 27, 2026 21:02 UTC |
Stellato Paul AVP, Controller, CAO
|
Exercise / conversionRestricted Stock Units · Derivative | 820 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001714585-26-000006 · form4-02272026_090231.xml · derivative · entry 3 Stellato Paul A · CIK 0001714585 · VP, Controller, CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,638 Underlying: Common Stock · 820 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: One-third of the RSUs vested on February 25, 2026. The remaining RSUs vest one-half on each of February 25, 2027 and February 25, 2028. F2 · derivative.expiration_date: One-third of the RSUs vested on February 25, 2026. The remaining RSUs vest one-half on each of February 25, 2027 and February 25, 2028. Read SEC document |
| February 25, 2026 Filed Feb 27, 2026 21:02 UTC |
Stellato Paul AVP, Controller, CAO
|
Tax withholdingCommon Stock | 402 | $99.51 | $40,003.02 |
DisclosureSEC source: 0001714585-26-000006 · form4-02272026_090231.xml · nonDerivative · entry 2 Stellato Paul A · CIK 0001714585 · VP, Controller, CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,527 F1 · shares: Represents shares withheld by Zimmer Biomet Holdings, Inc. (the "Company") to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs"). Read SEC document |
| February 25, 2026 Filed Feb 27, 2026 21:02 UTC |
Stellato Paul AVP, Controller, CAO
|
Exercise / conversionCommon Stock | 820 | $0.00 | $0.00 |
DisclosureSEC source: 0001714585-26-000006 · form4-02272026_090231.xml · nonDerivative · entry 1 Stellato Paul A · CIK 0001714585 · VP, Controller, CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,929 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 20, 2026 Filed Feb 25, 2026 02:03 UTC |
Phipps Chad FSee remarks below.
|
GrantRestricted Stock Units · Derivative | 9,818 | $0.00 | $0.00 |
DisclosureSEC source: 0001346672-26-000004 · form4-02252026_020224.xml · derivative · entry 4 Phipps Chad F · CIK 0001346672 · See remarks below. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,818 Underlying: Common Stock · 9,818 shares Expires not disclosed F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Company common stock. F4 · derivative.exercise_date: Vests annually over three years in increments of one-third each year, commencing February 20, 2027. F4 · derivative.expiration_date: Vests annually over three years in increments of one-third each year, commencing February 20, 2027. Read SEC document |
| February 20, 2026 Filed Feb 25, 2026 02:03 UTC |
Phipps Chad FSee remarks below.
|
Exercise / conversionRestricted Stock Units · Derivative | 2,246 | $0.00 | $0.00 |
DisclosureSEC source: 0001346672-26-000004 · form4-02252026_020224.xml · derivative · entry 3 Phipps Chad F · CIK 0001346672 · See remarks below. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,246 Underlying: Common Stock · 2,246 shares Expires 2026-02-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Company common stock. Read SEC document |
| February 20, 2026 Filed Feb 25, 2026 02:03 UTC |
Phipps Chad FSee remarks below.
|
Tax withholdingCommon Stock | 942 | $98.62 | $92,900.04 |
DisclosureSEC source: 0001346672-26-000004 · form4-02252026_020224.xml · nonDerivative · entry 2 Phipps Chad F · CIK 0001346672 · See remarks below. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 62,137 F2 · shares: Represents shares withheld by Zimmer Biomet Holdings, Inc. (the "Company") to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs"). Read SEC document |
| February 20, 2026 Filed Feb 25, 2026 02:03 UTC |
Phipps Chad FSee remarks below.
|
Exercise / conversionCommon Stock | 2,246 | $0.00 | $0.00 |
DisclosureSEC source: 0001346672-26-000004 · form4-02252026_020224.xml · nonDerivative · entry 1 Phipps Chad F · CIK 0001346672 · See remarks below. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 63,079 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 795 shares acquired under the Employee Stock Purchase Plan and pursuant to dividend reinvestment from May 1, 2025 through February 20, 2026. Read SEC document |
| February 20, 2026 Filed Feb 25, 2026 02:04 UTC |
Noor JehanzebSee remarks below.
|
GrantRestricted Stock Units · Derivative | 10,076 | $0.00 | $0.00 |
DisclosureSEC source: 0002059755-26-000002 · form4-02252026_020208.xml · derivative · entry 1 Noor Jehanzeb · CIK 0002059755 · See remarks below. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,076 Underlying: Common Stock · 10,076 shares Expires not disclosed F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Company common stock. F2 · derivative.exercise_date: Vests annually over three years in increments of one-third each year, commencing February 20, 2027. F2 · derivative.expiration_date: Vests annually over three years in increments of one-third each year, commencing February 20, 2027. Read SEC document |
| February 20, 2026 Filed Feb 25, 2026 02:01 UTC |
Yi SangGroup President, Asia Pacific
|
GrantRestricted Stock Units · Derivative | 9,043 | $0.00 | $0.00 |
DisclosureSEC source: 0001635943-26-000006 · form4-02252026_020249.xml · derivative · entry 3 Yi Sang · CIK 0001635943 · Group President, Asia Pacific 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,043 Underlying: Common Stock · 9,043 shares Expires not disclosed F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock. F2 · derivative.exercise_date: Vests annually over three years in increments of one-third each year, commencing February 20, 2027. F2 · derivative.expiration_date: Vests annually over three years in increments of one-third each year, commencing February 20, 2027. Read SEC document |
| February 20, 2026 Filed Feb 25, 2026 02:01 UTC |
Yi SangGroup President, Asia Pacific
|
Exercise / conversionRestricted Stock Units · Derivative | 2,382 | $0.00 | $0.00 |
DisclosureSEC source: 0001635943-26-000006 · form4-02252026_020249.xml · derivative · entry 2 Yi Sang · CIK 0001635943 · Group President, Asia Pacific 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,382 Underlying: Common Stock · 2,382 shares Expires 2026-02-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock. Read SEC document |
| February 20, 2026 Filed Feb 25, 2026 02:01 UTC |
Yi SangGroup President, Asia Pacific
|
Exercise / conversionCommon Stock | 2,382 | $0.00 | $0.00 |
DisclosureSEC source: 0001635943-26-000006 · form4-02252026_020249.xml · nonDerivative · entry 1 Yi Sang · CIK 0001635943 · Group President, Asia Pacific 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,052 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 20, 2026 Filed Feb 25, 2026 02:02 UTC |
Thornal Kevin RGrp Pres-Global Business
|
GrantRestricted Stock Units · Derivative | 27,385 | $0.00 | $0.00 |
DisclosureSEC source: 0001783992-26-000002 · form4-02252026_020242.xml · derivative · entry 1 Thornal Kevin R · CIK 0001783992 · Grp Pres-Global Business 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,385 Underlying: Common Stock · 27,385 shares Expires not disclosed F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Company common stock. F2 · derivative.exercise_date: Vests annually over three years in increments of one-third each year, commencing February 20, 2027. F2 · derivative.expiration_date: Vests annually over three years in increments of one-third each year, commencing February 20, 2027. Read SEC document |
| February 20, 2026 Filed Feb 25, 2026 02:01 UTC |
VAN ZUILEN WILFREDGroup Pres, EMEA
|
GrantRestricted Stock Units · Derivative | 10,334 | $0.00 | $0.00 |
DisclosureSEC source: 0001864818-26-000004 · form4-02252026_020207.xml · derivative · entry 4 VAN ZUILEN WILFRED · CIK 0001864818 · Group Pres, EMEA 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,334 Underlying: Common Stock · 10,334 shares Expires not disclosed F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Company common stock. F4 · derivative.exercise_date: Vests annually over three years in increments of one-third each year, commencing February 20, 2027. F4 · derivative.expiration_date: Vests annually over three years in increments of one-third each year, commencing February 20, 2027. Read SEC document |
| February 20, 2026 Filed Feb 25, 2026 02:01 UTC |
VAN ZUILEN WILFREDGroup Pres, EMEA
|
Exercise / conversionRestricted Stock Units · Derivative | 2,451 | $0.00 | $0.00 |
DisclosureSEC source: 0001864818-26-000004 · form4-02252026_020207.xml · derivative · entry 3 VAN ZUILEN WILFRED · CIK 0001864818 · Group Pres, EMEA 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,450 Underlying: Common Stock · 2,451 shares Expires 2026-02-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Company common stock. Read SEC document |
| February 20, 2026 Filed Feb 25, 2026 02:01 UTC |
VAN ZUILEN WILFREDGroup Pres, EMEA
|
Tax withholdingCommon Stock | 638 | $98.62 | $62,919.56 |
DisclosureSEC source: 0001864818-26-000004 · form4-02252026_020207.xml · nonDerivative · entry 2 VAN ZUILEN WILFRED · CIK 0001864818 · Group Pres, EMEA 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,455 F2 · shares: Represents shares withheld by Zimmer Biomet Holdings, Inc. (the "Company") to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs"). Read SEC document |
| February 20, 2026 Filed Feb 25, 2026 02:01 UTC |
VAN ZUILEN WILFREDGroup Pres, EMEA
|
Exercise / conversionCommon Stock | 2,451 | $0.00 | $0.00 |
DisclosureSEC source: 0001864818-26-000004 · form4-02252026_020207.xml · nonDerivative · entry 1 VAN ZUILEN WILFRED · CIK 0001864818 · Group Pres, EMEA 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,093 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 169 shares acquired under the Employee Stock Purchase Plan on June 30, 2025 and December 31, 2025. Read SEC document |
| February 20, 2026 Filed Feb 25, 2026 02:00 UTC |
Winkler LoriSVP and CHRO
|
GrantRestricted Stock Units · Derivative | 7,880 | $0.00 | $0.00 |
DisclosureSEC source: 0001852191-26-000004 · form4-02252026_020215.xml · derivative · entry 4 Winkler Lori · CIK 0001852191 · SVP and CHRO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,880 Underlying: Common Stock · 7,880 shares Expires not disclosed F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Company common stock. F3 · derivative.exercise_date: Vests annually over three years in increments of one-third each year, commencing February 20, 2027. F3 · derivative.expiration_date: Vests annually over three years in increments of one-third each year, commencing February 20, 2027. Read SEC document |
| February 20, 2026 Filed Feb 25, 2026 02:00 UTC |
Winkler LoriSVP and CHRO
|
Exercise / conversionRestricted Stock Units · Derivative | 1,845 | $0.00 | $0.00 |
DisclosureSEC source: 0001852191-26-000004 · form4-02252026_020215.xml · derivative · entry 3 Winkler Lori · CIK 0001852191 · SVP and CHRO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,844 Underlying: Common Stock · 1,845 shares Expires 2026-02-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Company common stock. Read SEC document |
| February 20, 2026 Filed Feb 25, 2026 02:00 UTC |
Winkler LoriSVP and CHRO
|
Tax withholdingCommon Stock | 683 | $98.62 | $67,357.46 |
DisclosureSEC source: 0001852191-26-000004 · form4-02252026_020215.xml · nonDerivative · entry 2 Winkler Lori · CIK 0001852191 · SVP and CHRO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,995 F1 · shares: Represents shares withheld by Zimmer Biomet Holdings, Inc. (the "Company") to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs"). Read SEC document |
| February 20, 2026 Filed Feb 25, 2026 02:00 UTC |
Winkler LoriSVP and CHRO
|
Exercise / conversionCommon Stock | 1,845 | $0.00 | $0.00 |
DisclosureSEC source: 0001852191-26-000004 · form4-02252026_020215.xml · nonDerivative · entry 1 Winkler Lori · CIK 0001852191 · SVP and CHRO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,678 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 20, 2026 Filed Feb 25, 2026 01:59 UTC |
Stellato Paul AVP, Controller, CAO
|
GrantRestricted Stock Units · Derivative | 4,651 | $0.00 | $0.00 |
DisclosureSEC source: 0001714585-26-000004 · form4-02252026_010232.xml · derivative · entry 5 Stellato Paul A · CIK 0001714585 · VP, Controller, CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,651 Underlying: Common Stock · 4,651 shares Expires not disclosed F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Company common stock. F5 · derivative.exercise_date: Vests in full on February 20, 2028. F5 · derivative.expiration_date: Vests in full on February 20, 2028. Read SEC document |
| February 20, 2026 Filed Feb 25, 2026 01:59 UTC |
Stellato Paul AVP, Controller, CAO
|
GrantRestricted Stock Units · Derivative | 2,842 | $0.00 | $0.00 |
DisclosureSEC source: 0001714585-26-000004 · form4-02252026_010232.xml · derivative · entry 4 Stellato Paul A · CIK 0001714585 · VP, Controller, CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,842 Underlying: Common Stock · 2,842 shares Expires not disclosed F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Company common stock. F4 · derivative.exercise_date: Vests annually over three years in increments of one-third each year, commencing February 20, 2027. F4 · derivative.expiration_date: Vests annually over three years in increments of one-third each year, commencing February 20, 2027. Read SEC document |
| February 20, 2026 Filed Feb 25, 2026 01:59 UTC |
Stellato Paul AVP, Controller, CAO
|
Exercise / conversionRestricted Stock Units · Derivative | 701 | $0.00 | $0.00 |
DisclosureSEC source: 0001714585-26-000004 · form4-02252026_010232.xml · derivative · entry 3 Stellato Paul A · CIK 0001714585 · VP, Controller, CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 701 Underlying: Common Stock · 701 shares Expires 2026-02-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Company common stock. Read SEC document |
| February 20, 2026 Filed Feb 25, 2026 01:59 UTC |
Stellato Paul AVP, Controller, CAO
|
Tax withholdingCommon Stock | 362 | $98.62 | $35,700.44 |
DisclosureSEC source: 0001714585-26-000004 · form4-02252026_010232.xml · nonDerivative · entry 2 Stellato Paul A · CIK 0001714585 · VP, Controller, CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,109 F2 · shares: Represents shares withheld by Zimmer Biomet Holdings, Inc. (the "Company") to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs"). Read SEC document |
| February 20, 2026 Filed Feb 25, 2026 01:59 UTC |
Stellato Paul AVP, Controller, CAO
|
Exercise / conversionCommon Stock | 701 | $0.00 | $0.00 |
DisclosureSEC source: 0001714585-26-000004 · form4-02252026_010232.xml · nonDerivative · entry 1 Stellato Paul A · CIK 0001714585 · VP, Controller, CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,471 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 60 shares acquired under the Employee Stock Purchase Plan on December 31, 2025. Read SEC document |
| February 20, 2026 Filed Feb 25, 2026 01:58 UTC |
Upadhyay SuketuExec VP, CFO
|
GrantRestricted Stock Units · Derivative | 21,701 | $0.00 | $0.00 |
DisclosureSEC source: 0001533149-26-000005 · form4-02252026_010204.xml · derivative · entry 4 Upadhyay Suketu · CIK 0001533149 · Exec VP, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,701 Underlying: Common Stock · 21,701 shares Expires not disclosed F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Company common stock. F3 · derivative.exercise_date: Vests annually over three years in increments of one-third each year, commencing February 20, 2027. F3 · derivative.expiration_date: Vests annually over three years in increments of one-third each year, commencing February 20, 2027. Read SEC document |
| February 20, 2026 Filed Feb 25, 2026 01:58 UTC |
Upadhyay SuketuExec VP, CFO
|
Exercise / conversionRestricted Stock Units · Derivative | 5,445 | $0.00 | $0.00 |
DisclosureSEC source: 0001533149-26-000005 · form4-02252026_010204.xml · derivative · entry 3 Upadhyay Suketu · CIK 0001533149 · Exec VP, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,445 Underlying: Common Stock · 5,445 shares Expires 2026-02-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Company common stock. Read SEC document |
| February 20, 2026 Filed Feb 25, 2026 01:58 UTC |
Upadhyay SuketuExec VP, CFO
|
Tax withholdingCommon Stock | 2,446 | $98.62 | $241,224.52 |
DisclosureSEC source: 0001533149-26-000005 · form4-02252026_010204.xml · nonDerivative · entry 2 Upadhyay Suketu · CIK 0001533149 · Exec VP, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 57,753 F1 · shares: Represents shares withheld by Zimmer Biomet Holdings, Inc. (the "Company") to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs"). Read SEC document |
| February 20, 2026 Filed Feb 25, 2026 01:58 UTC |
Upadhyay SuketuExec VP, CFO
|
Exercise / conversionCommon Stock | 5,445 | $0.00 | $0.00 |
DisclosureSEC source: 0001533149-26-000005 · form4-02252026_010204.xml · nonDerivative · entry 1 Upadhyay Suketu · CIK 0001533149 · Exec VP, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,199 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 20, 2026 Filed Feb 25, 2026 01:58 UTC |
Tornos IvanDirector · Chairman, President and CEO
|
GrantRestricted Stock Units · Derivative | 65,103 | $0.00 | $0.00 |
DisclosureSEC source: 0001757216-26-000004 · form4-02252026_010250.xml · derivative · entry 4 Tornos Ivan · CIK 0001757216 · Director · Chairman, President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 65,103 Underlying: Common Stock · 65,103 shares Expires not disclosed F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Company common stock. F4 · derivative.exercise_date: Vests annually over three years in increments of one-third each year, commencing February 20, 2027. F4 · derivative.expiration_date: Vests annually over three years in increments of one-third each year, commencing February 20, 2027. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.